This FMCG stock declined by 5% in the first half of Thursday’s trading session after its Q4 results came into sight.
Procter & Gamble Health Limited shares opened at Rs. Rs. 5,143.35 and fell to Rs. 5,036.10. This happened after the company published its financial results for the June quarter on 23rd August. However, the stock has given good returns over the years. In the last six months, the stock gave a return of 14.2% and 26.97% in the last year.
On 23rd August, 2023 the board announced a dividend of 500% of face value Rs. 10 per share. It is expected to be paid between November 28, 2023, to December 18, 2023. The company has a dividend yield of 1.25%.
The company follows the July to June period as their financial year.
Based on its financial year, the company released its Q4,2023 results. The revenue of the company declined by 5.9% from Rs. 32,589 crore to Rs. 30,664 crore. The net profit saw a huge fall of 49.6% from Rs. 5,919 crore to Rs. 2,982 crore for this quarter. The expenditure for the company has also increased since the last 2 quarters. This alone is one of the reasons for the decrease in net profit.
Procter & Gamble Health Limited, earlier known as Merck Limited deals with manufacturing of pharmaceuticals along with chemical products. Their products are sold globally. The focus of the company is to produce vitamins, supplements and minerals.
Written by Bhumika Khandelwal
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
